Corvese Brian

SEC source: 0001193125-26-379513 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,770

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0001193125-26-344599 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-08-05

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.

SEC source: 0001193125-26-253468 · ownership.xml · nonDerivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,137

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0001193125-26-187078 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,000

Underlying: Common Stock · 210,000 shares

Expires 2036-04-24

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.

SEC source: 0001193125-26-253468 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,693

F2 · price: Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely.

SEC source: 0001193125-26-004776 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,395

Underlying: Common Stock · 5,395 shares

Expires 2036-01-02

F1 · derivative.exercise_date: Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

SEC source: 0001193125-25-306681 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,053

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0001193125-25-201315 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,225

Underlying: Common Stock · 3,225 shares

Expires 2035-09-09

F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

SEC source: 0000950170-25-112884 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,441

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-25-088506 · ownership.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F2 · derivative.exercise_date: Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.

SEC source: 0000950170-25-088506 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires 2035-05-28

F1 · derivative.exercise_date: Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on May 28, 2026, and the balance vesting in equal quarterly installments thereafter.

SEC source: 0000950170-25-081610 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,151

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-25-033522 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,657

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-24-132524 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 426,283

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-24-103740 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,296

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-24-074839 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires 2034-01-26

F1 · derivative.exercise_date: Options were granted on January 26, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 26, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 15,000 Stock Options with an exercise price of $0.66.

SEC source: 0000950170-24-069211 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,494

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0001493152-24-012072 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

Underlying: PTIX Common Stock, Par Value $0.0001 · 43,750 shares

Expires 2034-03-25

SEC source: 0000950170-24-026421 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,527

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-24-046416 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-02-05

F1 · derivative.exercise_date: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 300,000 Stock Options with an exercise price of $0.63.

SEC source: 0000950170-23-068313 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,711

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000950170-23-046776 · ownership.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,523

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

F2 · balance_after: In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 9,931 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 317,279 instead of 317,505 as erroneously reported.

SEC source: 0000899243-23-015843 · doc4.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

SEC source: 0000899243-23-014415 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,505

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000899243-23-006922 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,348

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000899243-22-037653 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,795

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

F2 · balance_after: Amount owned includes 278,300 shares that were inadvertently excluded from a Form 4 filed on September 19, 2022.

SEC source: 0000899243-22-031523 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,646

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

SEC source: 0000899243-22-010700 · doc4.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-03-09

F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

SEC source: 0000899243-22-005243 · doc4.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2032-02-04

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023.

SEC source: 0000899243-21-025084 · doc4.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.

F2 · shares: On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.

F2 · price: On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.

F2 · derivative.exercise_date: On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.

F2 · derivative.expiration_date: On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.

SEC source: 0000899243-21-025084 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 16, 2020, Mr. Corvese was granted 22,471 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Mr. Corvese was issued the underlying 22,471 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 16, 2020, Mr. Corvese was granted 22,471 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Mr. Corvese was issued the underlying 22,471 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0000899243-21-027315 · doc4.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-12-17

F1 · derivative.exercise_date: Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022.

SEC source: 0001745285-20-000047 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-12-17

F1 · derivative.exercise_date: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The Stock Option vests in full on December 17, 2021 (provided Mr. Corvese continues to serve on the board on such date).

SEC source: 0001745285-20-000019 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,118 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.exercise_date: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.expiration_date: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000019 · primary_doc.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000015 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2030-06-16

F3 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021.

SEC source: 0001745285-20-000015 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,589

Underlying: Common Stock · 22,471 shares

Expires not disclosed

F1 · derivative.exercise_price: (1) Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.

F1 · derivative.expiration_date: (1) Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.

F2 · balance_after: Includes 27,118 Restricted Stock Units that are scheduled to vest on June 19, 2020.

SEC source: 0001493152-20-003035 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 120,000 shares

Expires 2030-02-21

F1 · price: As this was an option grant, there was no cost to the recipient.

SEC source: 0000899243-19-030105 · doc4.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-12-24

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on December 24, 2020.

SEC source: 0000899243-19-017843 · doc4.xml · derivative · entry 3

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,118

Underlying: Common Stock · 27,118 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020.

F2 · price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020.

F2 · derivative.expiration_date: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020.

SEC source: 0000899243-19-017843 · doc4.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,500

Underlying: Common Stock · 100,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020.

SEC source: 0000899243-19-017843 · doc4.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020.

SEC source: 0001288123-18-000016 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,276

Underlying: Common Stock · 21,276 shares

Expires 2019-04-19

F2 · derivative.exercise_price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

F2 · price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

F2 · derivative.exercise_date: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

SEC source: 0001288123-18-000016 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.

SEC source: 0000899243-18-009224 · doc4.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

F2 · derivative.exercise_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

F2 · derivative.expiration_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

SEC source: 0000899243-18-009224 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

SEC source: 0001437749-17-017263 · rdgdoc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 95,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 18 months

SEC source: 0001288123-17-000025 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2027-06-29

F2 · derivative.exercise_date: Option vest 100% on the one-year anniversary of the grant date.

SEC source: 0001288123-17-000025 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-06-29

F1 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting.

SEC source: 0001288123-17-000015 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,220

Underlying: Common Stock · 21,220 shares

Expires 2018-03-31

F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.